Regenxbio Overview
Regenxbio Target Price
Analysts' 12-month price predictions for RGNX.
Get informed when a big investor buys or sells
+ FollowShare Price
$9.95
Average Target Price
$18.75
88.4% upside
88.4% upside4 analysts in the last 4 months
High: $30 | Low: $12
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-15 | Morgan Stanley | $16 | 60.8% upside |  |
| 2026-05-15 | BarclaysEliana Merle | $12 | 20.6% upside | |
| 2026-03-09 | H.C. Wainwright | $30 | 201.5% upside | |
| 2026-03-05 | Morgan StanleyJudah Frommer | $17 | 70.9% upside | |
| 2026-02-10 | H.C. Wainwright | $32 | 221.6% upside | |
| 2026-02-10 | Robert W. BairdBrian Skorney | $27 | 171.4% upside | |
| 2026-02-10 | UBS | $18 | 80.9% upside | |
| 2026-02-10 | Goldman Sachs | $12 | 20.6% upside | |
| 2026-01-29 | H.C. WainwrightYi Chen | $34 | 241.7% upside | |
| 2026-01-27 | Barclays | $37 | 271.9% upside | |
| 2025-12-19 | Stifel Nicolaus | $45 | 352.3% upside | |
| 2025-12-15 | Leerink PartnersMani Foroohar | $20 | 101% upside | |
| 2025-03-18 | Leerink Partners | $24 | 141.2% upside | |
| 2025-01-07 | RBC CapitalLuca Issi | $30 | 201.5% upside | |
| 2024-11-15 | Morgan StanleyJudah Frommer | $22 | 121.1% upside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $18 | 80.9% upside | |
| 2024-09-05 | H.C. WainwrightYi Chen | $39 | 292% upside | |
| 2024-06-24 | Stifel NicolausAnnabel Samimy | $40 | 302% upside | |
| 2024-06-07 | Goldman SachsPaul Choi | $38 | 281.9% upside | |
| 2024-05-15 | H.C. WainwrightYi Chen | $38 | 281.9% upside | |
| 2024-03-11 | H.C. WainwrightYi Chen | $36 | 261.8% upside | |
| 2024-03-08 | RBC CapitalLuca Issi | $35 | 251.8% upside | |